Reference
·Supporting source
Pharmacy and medical channel share of cannabis sales (2025e)
~30-35% (rising)
Pharmacy and formal medical channels — covering FDA-licensed pharmacies, hospital outpatient dispensaries (GPO supply chain), and clinic-attached medical-cannabis workflows — accounted for an estimated 30-35% of Thailand's cannabis-product retail value in 2025 per UTCC and Krungsri Research segmentation, up from <10% in 2023 when recreational-grey storefronts dominated. The recriminalisation effectively redirects volume from recreational storefronts toward medical-prescription channels. CBD wellness skews to drugstore retail (Boots Thailand, Watsons, BIG C health-and-beauty); high-THC medical flower and tincture skews to GPO and hospital channels. The mix shift advantages pharmacy-chain operators and GPO over recreational storefronts.
Figure in context
Pharmacy and formal medical channels — covering FDA-licensed pharmacies, hospital outpatient dispensaries (GPO supply chain), and clinic-attached medical-cannabis workflows — accounted for an estimated 30-35% of Thailand's cannabis-product retail value in 2025 per UTCC and Krungsri Research segmentation, up from <10% in 2023 when recreational-grey storefronts dominated. The recriminalisation effectively redirects volume from recreational storefronts toward medical-prescription channels. CBD wellness skews to drugstore retail (Boots Thailand, Watsons, BIG C health-and-beauty); high-THC medical flower and tincture skews to GPO and hospital channels. The mix shift advantages pharmacy-chain operators and GPO over recreational storefronts.
Pharmacy and formal medical channels — covering FDA-licensed pharmacies, hospital outpatient dispensaries (GPO supply chain), and clinic-attached medical-cannabis workflows — accounted for an estimated 30-35% of Thailand's cannabis-product retail value in 2025 per UTCC and Krungsri Research segmentation, up from <10% in 2023 when recreational-grey storefronts dominated. The recriminalisation effectively redirects volume from recreational storefronts toward medical-prescription channels. CBD wellness skews to drugstore retail (Boots Thailand, Watsons, BIG C health-and-beauty); high-THC medical flower and tincture skews to GPO and hospital channels. The mix shift advantages pharmacy-chain operators and GPO over recreational storefronts.
Time scope
2025 estimate
Source basis
Supporting source
Interpretation notes
What this tells you
Pharmacy and formal medical channels — covering FDA-licensed pharmacies, hospital outpatient dispensaries (GPO supply chain), and clinic-attached medical-cannabis workflows — accounted for an estimated 30-35% of Thailand's cannabis-product retail value in 2025 per UTCC and Krungsri Research segmentation, up from <10% in 2023 when recreational-grey storefronts dominated. The recriminalisation effectively redirects volume from recreational storefronts toward medical-prescription channels. CBD wellness skews to drugstore retail (Boots Thailand, Watsons, BIG C health-and-beauty); high-THC medical flower and tincture skews to GPO and hospital channels. The mix shift advantages pharmacy-chain operators and GPO over recreational storefronts.
What not to do with it
Use the linked report for interpretation and keep basis differences explicit.
Related figures
Adjacent numbers that add context without drowning the value.
Thailand licensed cannabis dispensary count (2022-2025)
Ministry of Public Health, FDA Thailand, Bangkok Post cannabis policy tracking
Thailand cannabis market size (2022-2025)
Prohibition Partners Asia Cannabis Report, University of the Thai Chamber of Commerce, Krungsri Research, SCB EIC
Thailand hemp and CBD-product export value (2020-2024)
Thai Customs export data, 3304 CBD-bearing cosmetics, 1518 hemp oil), Thai FDA, Ministry of Commerce
Thailand medical cannabis cultivation and processing licences
Thai FDA Narcotics Control Division, Ministry of Public Health Department of Thai Traditional and Alternative Medicine, Government Pharmaceutical Organization
ASEAN cannabis policy comparison (2024)
Prohibition Partners ASEAN Cannabis Report, ASEAN Ministerial Meeting on Drug Matters disclosures, regional cannabis policy trackers
Thailand cannabis policy timeline (2018-2024)
Royal Thai Government Gazette, Ministry of Public Health policy disclosures, Bangkok Post and Thai PBS legislative coverage
Report context
Atlas actors in this figure's reports
Profiles covered in the report that cite this number.